TrialAmerican journal of clinical oncology2014

Phase II study of temozolomide (TMZ) and everolimus (RAD001) therapy for metastatic melanoma: a North Central Cancer Treatment Group study, N0675.

Roxana S Dronca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.